Older patients benefit from brentuximab treatmentJanuary 6, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Ibrutinib proves active in high-risk CLLJanuary 6, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug gets orphan designation for WMJanuary 4, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Certain cancers primarily result from ‘bad luck’January 3, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesAMLNon-Hodgkin Lymphoma
CARs come in different makes and modelsJanuary 2, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALL
CAR is feasible in majority of ALL patients, team saysJanuary 2, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALL
CAR produces durable responses in B-cell ALLJanuary 2, 2015Leukemia, Myelodysplasia, TransplantationALL
New data added to obinutuzumab labelJanuary 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma